Introduction Executive Summary Rosacea: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Rosacea – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Rosacea companies’ collaborations, Licensing, Acquisition -Deal Value Trends Rosacea Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis CLS 005: Cutanea Life Sciences • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis BMX-010: BioMimetix • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Lotilaner: Tarus pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery Stage Products • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Rosacea Key Companies Rosacea Key Products Rosacea- Unmet Needs Rosacea- Market Drivers and Barriers Rosacea- Future Perspectives and Conclusion Rosacea Analyst Views Rosacea Key Companies Appendix

Table 1 Total Products for Rosacea Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Sol-Gel Technologies, Ltd. • Novartis Pharmaceuticals • Maruho Co., Ltd. • Galderma R&D • Foamix Ltd. • Dr. Reddy's Laboratories Limited • Dermata Therapeutics • DeNova Research • CAGE Bio Inc. • BioPharmX, Inc. • BioMimetix JV, LLC • Azitra Inc. • AOBiome LLC • Allergan • AiViva BioPharma, Inc.